What lab workup is recommended for patients presenting with phantosmia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Lab Workup for Phantosmia

For patients presenting with phantosmia, no specific laboratory testing is routinely indicated unless there are clinical features suggesting an underlying systemic or neurological condition.

Initial Clinical Assessment

The evaluation of phantosmia should focus on distinguishing between unirhinal (one nostril) and birhinal (both nostrils) presentations, as these represent distinct clinical entities with different underlying mechanisms 1. A detailed history should specifically assess:

  • Laterality: Whether the phantosmia is unilateral or bilateral, as unirhinal phantosmia represents a distinct syndrome that can often be initiated or inhibited by physiological maneuvers like coughing, laughing, or Valsalva 1, 2
  • Temporal pattern: Whether episodes are cyclic and can be voluntarily initiated/inhibited (suggesting unirhinal phantosmia) versus continuous and non-modifiable (suggesting birhinal phantosmia) 1
  • Associated symptoms: Presence of hyposmia (reduced smell), which is common in birhinal phantosmia but rare in unirhinal phantosmia 1
  • Onset triggers: Spontaneous versus post-infectious, post-traumatic, or medication-related 1

Laboratory Testing Strategy

No routine laboratory workup is recommended for isolated phantosmia. The evidence demonstrates that idiopathic phantosmia is generally a benign condition that improves or resolves in approximately 57% of patients over 5 years without identifying serious underlying pathology 3.

However, targeted laboratory testing may be reasonable in specific clinical contexts:

  • Thyroid function tests: Consider if there are clinical signs or symptoms of thyroid dysfunction, as metabolic disorders can occasionally present with chemosensory disturbances 4
  • Metabolic panel: May be considered if systemic illness is suspected based on history and physical examination 4

Essential Diagnostic Studies

Olfactory Function Testing

  • Formal psychophysical testing using validated instruments (e.g., Sniffin' Sticks, UPSIT) should be performed to objectively assess olfactory function and document the presence or absence of hyposmia 5
  • This testing helps distinguish between phantosmia with preserved olfaction (more common in unirhinal cases) versus phantosmia with hyposmia (typical of birhinal cases) 1

Neuroimaging

  • Brain MRI is not routinely indicated for isolated phantosmia without red flag symptoms 3
  • Consider structural brain imaging (CT or MRI) only if there are concerning features such as:
    • Focal neurological deficits
    • Progressive symptoms
    • Associated headaches or visual changes
    • Unilateral presentation with other cranial nerve abnormalities 4

Electroencephalography (EEG)

  • EEG may be considered in patients with cyclic unirhinal phantosmia, as these patients frequently demonstrate ipsilateral sharp waves suggesting focal cortical irritability 1
  • EEG is generally not helpful in birhinal phantosmia cases 1

Clinical Pitfalls to Avoid

Do not order extensive laboratory panels or imaging studies reflexively. The research clearly demonstrates that idiopathic phantosmia rarely heralds serious neurological disease, including Parkinson's disease, despite historical concerns 3. Over 5 years of follow-up, none of the 44 patients with idiopathic phantosmia developed severe health conditions 3.

Do not assume phantosmia requires aggressive intervention. More than half of patients experience spontaneous improvement or resolution, with 31.8% experiencing complete disappearance and 25% experiencing improvement after 5 years 3.

Do not overlook the distinction between unirhinal and birhinal phantosmia, as treatment approaches differ significantly. Unirhinal phantosmia may respond to peripheral interventions or medications that enhance GABAergic activity, while birhinal phantosmia typically requires different management 1.

Prognosis and Reassurance

The natural history of idiopathic phantosmia is generally favorable, with approximately 57% of patients experiencing improvement or resolution over 5 years, 38.7% remaining stable, and less than 5% worsening 3. This benign prognosis should guide the extent of diagnostic workup and help frame patient counseling.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.